Dynavax Technologies
DVAX
#5071
Rank
โ‚น170.93 B
Marketcap
โ‚น1,456
Share price
0.00%
Change (1 day)
17.23%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -โ‚น2.79 Billion

According to Dynavax Technologies 's latest financial reports the company's current earnings are โ‚น0.33 Billion. In 2024 the company made an earning of โ‚น3.53 Billion, an increase over its 2023 earnings that were of โ‚น0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.79 Billion-178.82%
2024 โ‚น3.53 B1475.31%
2023 โ‚น0.22 B-99.2%
2022 โ‚น28.22 B238.78%
2021 โ‚น8.33 B-257.89%
2020 -โ‚น5.28 Billion-58.58%
2019 -โ‚น12.74 Billion-9.32%
2018 -โ‚น14.05 Billion60.44%
2017 -โ‚น8.76 Billion-15.8%
2016 -โ‚น10.4 Billion4.22%
2015 -โ‚น9.98 Billion16.54%
2014 -โ‚น8.57 Billion37.09%
2013 -โ‚น6.25 Billion
2010 -โ‚น4.47 Billion214.85%
2009 -โ‚น1.42 Billion-37.33%
2008 -โ‚น2.27 Billion-66.07%
2007 -โ‚น6.68 Billion16.92%
2006 -โ‚น5.72 Billion170.36%
2005 -โ‚น2.12 Billion33.39%
2004 -โ‚น1.59 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น648.69 B-20,481.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น966.13 B-30,455.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น94.98 B-3,084.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น183.61 Billion 5,669.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น722.22 B-22,792.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.346 T-42,392.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น671.93 B-21,212.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
โ‚น14.18 B-545.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น150.73 B-4,836.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel